Novel methods of treating hearing loss
US-2024390323-A1 · Nov 28, 2024 · US
Transdermal preparation comprising a ropinirole derivative
US9238025B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9238025-B2 |
| Application number | US-201013319401-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 7, 2010 |
| Priority date | May 21, 2009 |
| Publication date | Jan 19, 2016 |
| Grant date | Jan 19, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to a transdermal preparation having a backing and an adhesive layer laminated on the backing, wherein the adhesive layer contains 4-ethylene-2(3H)-indolone and a physiologically active compound, and wherein the 4-ethylene-2(3H)-indolone is present in an amount from 0.001 to 4 mass % of the total mass of components of the adhesive layer.
First claim
Opening claim text (preview).
The invention claimed is: 1. A transdermal preparation comprising a backing and an adhesive layer laminated on the backing, wherein the adhesive layer contains 4-ethylene-2(3H)-indolone and a physiologically active compound, wherein the physiologically active compound is ropinirole hydrochloride, and wherein the 4-ethylene-2(3H)-indolone is present in an amount from 0.01 to 4 mass % of the total mass of components of the adhesive layer.
Assignees
Inventors
Classifications
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Anti-Parkinson drugs · CPC title
- A61K31/404Primary
Indoles, e.g. pindolol · CPC title
Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin · CPC title
Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9238025B2 cover?
- The present invention relates to a transdermal preparation having a backing and an adhesive layer laminated on the backing, wherein the adhesive layer contains 4-ethylene-2(3H)-indolone and a physiologically active compound, and wherein the 4-ethylene-2(3H)-indolone is present in an amount from 0.001 to 4 mass % of the total mass of components of the adhesive layer.
- Who is the assignee on this patent?
- Uchida Naoyuki, Takagi Yuka, Takada Yasunori, and 1 more
- What technology area does this patent fall under?
- Primary CPC classification A61K31/404. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).